Antiglycation Potential of Metal Ions and Polyphenolic Extract of Chickpea on Thiol-protease Inhibitor: A Management for Diabetic Complications

Overview

Journal Saudi Pharm J

Specialty Pharmacy

Date 2024 Jan 5

PMID 38178850

Authors

Mohd Shahnawaz Khan

Sheraz Ahmad Bhat

Monnera Saud Albagmi

Mohammed Arshad

Mohammad Tarique

Bilqees Bano

Affiliations

Soon will be listed here.

Abstract

Glycation is the non-enzymatic adduct formation between reducing sugars or dicarbonyls with proteins and is a crucial molecular event under hyperglycaemic conditions of diabetes. The accumulation of advanced glycation end products (AGEs) due to glycation of proteins has been implicated in several diseases associated with ageing and diabetes. Thus, investigating the antiglycation potential of some trace metal ions (Manganese; Mn, and Zinc; Zn) and polyphenolic extract of chickpea seeds (PEC) on the methylglyoxal (MGO) induced glycation of a phytocystatin isolated from chickpea was taken up to find an inexpensive and non-toxic therapeutic means of medicating protein glycation and associated diabetic complications. The current study focused on the comparative analyses of these micronutrients and herbal extracts in inhibiting protein glycation and AGEs formation in a quest to develop nutraceuticals for managing diabetes. The effect of metals (Mn, Zn) and PEC on protein glycation was assessed by different techniques, i.e., glycation-specific AGE fluorescence and absorbance, thiol protease inhibitory activity assay, and conformational alterations by spectroscopic assays. This study revealed the significant anti-glycation potencies of Mn, Zn, and PEC against the MGO-induced glycation of CPC, which might pave the way for resolving pathological complications of diabetes by combining higher levels of efficacy, selectivity, and safety in humans. Moreover, characterization and identification of different AGEs formed during the glycation process in diabetics was done to apply the same for determining the onset of glycation at the early stage so that appropriate steps be taken to address the menace of diabetic complications.

References

Islam B, Khan M, Husain F, Rehman M, Zughaibi T, Abuzenadah A . mTOR Targeted Cancer Chemoprevention by Flavonoids. Curr Med Chem. 2020; 28(39):8068-8082. DOI: 10.2174/0929867327666201109122025. View

Srey C, Haughey S, Connolly L, Del Castillo M, Ames J, Elliott C . Immunochemical and mass spectrometric analysis of Nε-(carboxymethyl)lysine content of AGE-BSA systems prepared with and without selected antiglycation agents. J Agric Food Chem. 2010; 58(22):11955-61. DOI: 10.1021/jf102543g. View

Fournet M, Bonte F, Desmouliere A . Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging. Aging Dis. 2018; 9(5):880-900. PMC: 6147582. DOI: 10.14336/AD.2017.1121. View

Srivastava S, Ansari N, Bhatnagar A, Hair G, Liu S, Das B . Activation of aldose reductase by nonenzymatic glycosylation. Prog Clin Biol Res. 1989; 304:171-84. View

Ahmed N . Advanced glycation endproducts--role in pathology of diabetic complications. Diabetes Res Clin Pract. 2004; 67(1):3-21. DOI: 10.1016/j.diabres.2004.09.004. View

Griffiths D . The inhibition of digestive enzymes by polyphenolic compounds. Adv Exp Med Biol. 1986; 199:509-16. DOI: 10.1007/978-1-4757-0022-0_29. View

Kaeser S, Herzig M, Coomaraswamy J, Kilger E, Selenica M, Winkler D . Cystatin C modulates cerebral beta-amyloidosis. Nat Genet. 2007; 39(12):1437-9. DOI: 10.1038/ng.2007.23. View

Phillips S, Thornalley P . The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem. 1993; 212(1):101-5. DOI: 10.1111/j.1432-1033.1993.tb17638.x. View

Al-Maroof R, Al-Sharbatti S . Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics. Saudi Med J. 2006; 27(3):344-50. View

10.

Zughaibi T, Suhail M, Tarique M, Tabrez S . Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach. Int J Mol Sci. 2021; 22(22). PMC: 8621356. DOI: 10.3390/ijms222212455. View

11.

Khan M, Qais F, Rehman M, Ismail M, Alokail M, Altwaijry N . Mechanistic inhibition of non-enzymatic glycation and aldose reductase activity by naringenin: Binding, enzyme kinetics and molecular docking analysis. Int J Biol Macromol. 2020; 159:87-97. DOI: 10.1016/j.ijbiomac.2020.04.226. View

12.

Peng X, Ma J, Chen F, Wang M . Naturally occurring inhibitors against the formation of advanced glycation end-products. Food Funct. 2011; 2(6):289-301. DOI: 10.1039/c1fo10034c. View

13.

Tarwadi K, Agte V . Effect of micronutrients on methylglyoxal-mediated in vitro glycation of albumin. Biol Trace Elem Res. 2010; 143(2):717-25. DOI: 10.1007/s12011-010-8915-7. View

14.

Eble A, Thorpe S, Baynes J . Nonenzymatic glucosylation and glucose-dependent cross-linking of protein. J Biol Chem. 1983; 258(15):9406-12. View

15.

Van Chuyen N . Toxicity of the AGEs generated from the Maillard reaction: on the relationship of food-AGEs and biological-AGEs. Mol Nutr Food Res. 2006; 50(12):1140-9. DOI: 10.1002/mnfr.200600144. View

16.

Hetz C, Saxena S . ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017; 13(8):477-491. DOI: 10.1038/nrneurol.2017.99. View

17.

Tupe R, Kemse N, Khaire A, Shaikh S . Attenuation of glycation-induced multiple protein modifications by Indian antidiabetic plant extracts. Pharm Biol. 2016; 55(1):68-75. PMC: 7011994. DOI: 10.1080/13880209.2016.1228683. View

18.

Ghiassi Tarzi B, Gharachorloo M, Baharinia M, Mortazavi S . The effect of germination on phenolic content and antioxidant activity of chickpea. Iran J Pharm Res. 2013; 11(4):1137-43. PMC: 3813166. View

19.

Rasheed S, Sanchez S, Yousuf S, Honore S, Choudhary M . Drug repurposing: In-vitro anti-glycation properties of 18 common drugs. PLoS One. 2018; 13(1):e0190509. PMC: 5754062. DOI: 10.1371/journal.pone.0190509. View

20.

Cochrane S, Robinson G . In vitro glycation of glomerular basement membrane alters its permeability: a possible mechanism in diabetic complications. FEBS Lett. 1995; 375(1-2):41-4. DOI: 10.1016/0014-5793(95)01171-a. View